These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 19923120)

  • 21. Vocal cord paralysis in myasthenia gravis with anti-MuSK antibodies.
    Hara K; Mashima T; Matsuda A; Tanaka K; Tomita M; Shiraishi H; Motomura M; Nishizawa M
    Neurology; 2007 Feb; 68(8):621-2. PubMed ID: 17310039
    [No Abstract]   [Full Text] [Related]  

  • 22. Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction.
    Cole RN; Reddel SW; Gervásio OL; Phillips WD
    Ann Neurol; 2008 Jun; 63(6):782-9. PubMed ID: 18384168
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Immunologic aspects of disorders of neuromuscular transmission. 1. Myasthenia gravis].
    Andreis I; Lovnicki TJ; Beara N; Taradi M
    Lijec Vjesn; 1994; 116(5-6):154-8. PubMed ID: 7968204
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myasthenia gravis: acetylcholine receptor antibodies and beyond.
    Burde RM
    J Clin Neuroophthalmol; 1981 Mar; 1(1):63-6. PubMed ID: 6213647
    [No Abstract]   [Full Text] [Related]  

  • 25. [Myasthenia gravis and other neuromuscular diseases].
    Pirskanen R
    Duodecim; 1979; 95(21):1401-11. PubMed ID: 527509
    [No Abstract]   [Full Text] [Related]  

  • 26. [Long-term follow-up study of anti-acetylcholine receptor antibody titers and clinical symptoms in patients with myasthenia gravis].
    Komiya T; Sato T
    Rinsho Shinkeigaku; 1988 Jul; 28(7):727-34. PubMed ID: 3233845
    [No Abstract]   [Full Text] [Related]  

  • 27. [Pathogenesis of myasthenia gravis].
    Téllez Zenteno JF; Morales Buenrostro LE; Torre Delgadillo A
    Rev Invest Clin; 2000; 52(1):80-5. PubMed ID: 10818814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increasing incidence of myasthenia gravis among elderly in British Columbia, Canada.
    Pakzad Z; Aziz T; Oger J
    Neurology; 2011 Apr; 76(17):1526-8. PubMed ID: 21519005
    [No Abstract]   [Full Text] [Related]  

  • 29. [Myasthenia gravis in newborn infants--pathological mechanism, clinical symptomatology and therapeutic procedures].
    Krauze M; Musialik E; Swietliński J; Litwa K; Latko E; Górny J; Sobczyk J
    Wiad Lek; 1992 Aug; 45(15-16):610-4. PubMed ID: 1488831
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myasthenia gravis.
    West J Med; 1979 May; 130(5):438-43. PubMed ID: 516668
    [No Abstract]   [Full Text] [Related]  

  • 31. Humoral immunity in myasthenia gravis: immunoglobulin class, affinity, and antigenic site.
    Tindall RS
    Trans Am Neurol Assoc; 1979; 104():16-8. PubMed ID: 553397
    [No Abstract]   [Full Text] [Related]  

  • 32. The pathogenesis of myasthenia gravis.
    Fulpius BW
    Bull Schweiz Akad Med Wiss; 1978 Mar; 34(1-3):25-31. PubMed ID: 667413
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Myasthenia gravis (1). Experimental myasthenia gravis--a tool for the study of the pathogenesis, diagnosis and treatment of myasthenia gravis].
    Heilbronn E
    Lakartidningen; 1978 Oct; 75(41):3663-4, 3669. PubMed ID: 692231
    [No Abstract]   [Full Text] [Related]  

  • 34. Acquired canine myasthenia gravis: immunocytochemical localization of immune complexes at neuromuscular junctions.
    Pflugfelder CM; Cardinet GH; Lutz H; Holliday TA; Hansen RJ
    Muscle Nerve; 1981; 4(4):289-95. PubMed ID: 7019698
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic and antibody-mediated channelopathies at the neuromuscular junction.
    Vincent A; Mills K
    Electroencephalogr Clin Neurophysiol Suppl; 1999; 50():250-8. PubMed ID: 10689470
    [No Abstract]   [Full Text] [Related]  

  • 36. Adult onset acquired myasthenia gravis in three Great Dane littermates.
    Kent M; Glass EN; Acierno M; Shelton GD
    J Small Anim Pract; 2008 Dec; 49(12):647-50. PubMed ID: 18684140
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Musk-antibody positive myasthenia gravis presenting with isolated neck extensor weakness.
    Casasnovas C; Povedano M; Jaumà S; Montero J; Martínez-Matos JA
    Neuromuscul Disord; 2007 Jul; 17(7):544-6. PubMed ID: 17533129
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasmapheresis for myasthenia gravis.
    Med Lett Drugs Ther; 1979 Jul; 21(15):64. PubMed ID: 470831
    [No Abstract]   [Full Text] [Related]  

  • 39. Autoimmune disorders of the neuromuscular junction.
    Lang B; Vincent A
    Curr Opin Pharmacol; 2009 Jun; 9(3):336-40. PubMed ID: 19428298
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acetylcholine nicotinic receptor: a key molecule for the pathogenesis of myasthenia gravis.
    Sher E; Gotti C; Clementi F
    Ann Ist Super Sanita; 1988; 24(1):103-16. PubMed ID: 3289434
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.